TScan Therapeutics, Inc. (TCRX)
NASDAQ·Healthcare·Biotechnology
$1.27
-3.44%
Mkt Cap $73.13M
Analyst Ratings
Buy
3
Hold
1
Sell
0
Price Target (2 analysts)
$7.50
Range $3.00 – $12.00
Implied Upside
+492.9%
Consensus $7.50 vs current $1.27
NASDAQ·Healthcare·Biotechnology
$1.27
-3.44%
Mkt Cap $73.13M
Buy
3
Hold
1
Sell
0
Price Target (2 analysts)
$7.50
Range $3.00 – $12.00
+492.9%
Consensus $7.50 vs current $1.27